"GLOBAL DEVELOPMENT" is focused on developing and manufacturing non infringing generic medicines in Europe and has he intellectual property to cover a broad portfolio of generic and niche products. Our product development expertise has lead to formulation advancements which have expanded the applications of our technologies platform to enable formulations that can enhance the product safety in multiple ways. The company cover the full range from single-center to multi-national projects, offering professional Management and services for International - National pharmaceutical companies. The "GLOBAL DEVELOPMENT" team is dedicated and professional, with a wide range of academic competence and solid experience in global generic market as well as of interacting with the various regulatory authorities worldwide At GLOBAL DEVELOPMENT we are highly aware of the fact that our clients need to cut timelines and be cost-effective when bringing an investigational product up to registration. We execute and support registration procedures in all worldwide countries, with experienced native-speaking experts and we handle all regulatory and ethical submissions, as well as local monitoring services and support-to-site. This together with an excellent network of local investigators will speed up the regulatory processes, as well as facilitating communication. We are proud that many well-known pharmaceutical companies are placing their trust in us. Their trust is earned due to our expert services. Together with our clients we always think one step ahead to develop innovative concepts and solutions
| Website | http://globaldevelopment.eu |
| Revenue | $8 million |
| Employees | 7 (7 on RocketReach) |
| Founded | 2004 |
| Phone | +1 804-304-4483 |
| Technologies | |
| Industry | Pharmaceutical Manufacturing, Drug Manufacturing & Research, Pharmaceuticals, Healthcare |
| Keywords | Generic Medicines, Pharmaceutical Manufacturing, Drug Development, Generic Drugs, Niche Pharmaceuticals, Medicine Production, Product Development, European Pharmaceuticals, Generic Drug Manufacturing, Pharmaceutical Portfolio, Pharmaceutical Production, Healthcare Manufacturing, Health Products, Medicines Development, Pharmaceutical Research, Global Health |
| Competitors | McKinsey & Company, AECOM, IFC - International Finance Corporation, Tetra Tech, RTI International, Chemonics International, FHI 360, DAI, Palladium: Make It Possible, Abt Associates +51 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies |
Looking for a particular global development employee's phone or email?
The global development annual revenue was $8 million in 2026.
Fayçal Beldjilali is the Ceo, founder of global development.
7 people are employed at global development.
The NAICS codes for global development are [32541, 325, 32, 3254].
The SIC codes for global development are [28, 283].